NINDS Funding Strategy FY 2020

NINDS Funding Strategy FY 2020

On December 20, 2019, President Trump signed H.R. 1865 Further Consolidated Appropriations Act, 2020 and NINDS and NIH received a full year appropriation. Though still awaiting final approval on NIH funding policy and details of the appropriation, NINDS is issuing this updated interim funding guidance based upon the expected final appropriation.

Competing Applications

The table below describes the paylines for different categories of new and competing applications. The payline applies to the following activities: R01, R03, R15, and R21. Applications within these paylines will be funded with rare, NANDS Council-approved exceptions.

Investigators General Pay Line
All Investigators 16%
Early Stage Investigators 25% (only R01s)

In addition, Alzheimer's disease and Alzheimer's disease related dementia applications submitted via the parent R01 or the NINDS R21 funding opportunity announcement will share an extended payline with NIA as described in the NIA Funding Strategy.

Non-competing Continuation Awards

NINDS will pay FY2020 non-competing awards at their full committed level as shown in the Notice of Award and will restore cuts made in non-competing awards paid earlier in this fiscal year.

Administrative Reductions

Applications submitted for Council review on or before September 2019

Reflecting long-standing NINDS policy, in general, modular grants will be subject to a 12.5% administrative reduction from the Council-recommended direct costs. Non-modular grants that exceed $250, 000 direct costs in any year will be subject to a 17.5% administrative reduction from the Council recommended direct costs.

Applications submitted for Council review for January 2020 or later
In response to the increase in the NINDS appropriation, beginning in January 2020 modular grants will generally be subject to only a 6% administrative reduction from the Council-recommended direct costs.  Non-modular grants that exceed $250, 000 direct costs in any year will still be subject to a 17.5% administrative reduction from the Council recommended direct costs.